Cyclohexyl-octahydro-pyrrolo[1,2-a] pyrazine-based inhibitors of human N-myristoyltransferase-1

被引:31
作者
French, KJ [1 ]
Zhuang, Y [1 ]
Schrecengost, RS [1 ]
Copper, JE [1 ]
Xia, ZP [1 ]
Smith, CD [1 ]
机构
[1] Penn State Coll Med, Dept Pharmacol, Hershey, PA 17033 USA
关键词
D O I
10.1124/jpet.103.061572
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
N-Myristoyltransferase (NMT) is an emerging therapeutic target that catalyzes the attachment of myristate to the N terminus of an acceptor protein. We have developed a medium-throughput assay for screening potential small molecule inhibitors of human NMT-1 consisting of recombinant enzyme, biotinylated peptide substrate, and [H-3] myristoyl-CoA. Approximately 16,000 diverse compounds have been evaluated, and significant inhibition of NMT was found with 0.8% of the compounds. From these hits, we have identified the cyclohexyl-octahydropyrrolo[ 1,2-a] pyrazine (COPP) chemotype as inhibitory toward human NMT-1. Thirty-two compounds containing this substructure inhibited NMT-1, with IC50 values ranging from 6 muM to millimolar concentrations, and a quantitative structure-activity relationship equation (r(2) = 0.72) was derived for the series. The most potent inhibitor (24, containing 9-ethyl-9H-carbazole) demonstrated competitive inhibition for the peptide-binding site of NMT-1 and noncompetitive inhibition for the myristoyl-CoA site. Computational docking studies using the crystal structure of the highly homologous yeast NMT confirmed that 24 binds with excellent complementarity to the peptide-binding site of the enzyme. To evaluate the ability of 24 to inhibit NMT activity in intact cells, monkey CV-1 cells expressing an N-myristoylated green fluorescent protein (GFP) fusion protein were treated with a known NMT inhibitor or with 24. Each compound caused the redistribution of GFP from the plasma membrane to the cytosol. Furthermore, 24 inhibits cancer cell proliferation at doses similar to those that inhibit protein myristoylation. Overall, these studies establish an efficient assay for screening for inhibitors of human NMT and identify a novel family of inhibitors that compete at the peptide-binding site and have activity in intact cells.
引用
收藏
页码:340 / 347
页数:8
相关论文
共 40 条
  • [11] Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase.: Part 2
    Ebiike, H
    Masubuchi, M
    Liu, PL
    Kawasaki, K
    Morikami, K
    Sogabe, S
    Hayase, M
    Fujii, T
    Sakata, K
    Shindoh, H
    Shiratori, Y
    Aoki, Y
    Ohtsuka, T
    Shimma, N
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (04) : 607 - 610
  • [12] Blockage of N-myristoylation of HIV-1 gag induces the production of impotent progeny virus
    Furuishi, K
    Matsuoka, H
    Takama, M
    Takahashi, I
    Misumi, S
    Shoji, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 237 (03) : 504 - 511
  • [13] Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells
    Garcia, R
    Bowman, TL
    Niu, GL
    Yu, H
    Minton, S
    Muro-Cacho, CA
    Cox, CE
    Falcone, R
    Fairclough, R
    Parsons, S
    Laudano, A
    Gazit, A
    Levitzki, A
    Kraker, A
    Jove, R
    [J]. ONCOGENE, 2001, 20 (20) : 2499 - 2513
  • [14] A second mammalian N-myristoyltransferase
    Giang, DG
    Cravatt, BF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (12) : 6595 - 6598
  • [15] ALTERED MEMBRANE ASSOCIATION OF P60V-SRC AND A MURINE 63-KDA N-MYRISTOYL PROTEIN AFTER INCORPORATION OF AN OXYGEN-SUBSTITUTED ANALOG OF MYRISTIC ACID
    HEUCKEROTH, RO
    GORDON, JI
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (14) : 5262 - 5266
  • [16] ROUS-SARCOMA VIRUS TRANSFORMING PROTEIN LACKING MYRISTIC ACID PHOSPHORYLATES KNOWN POLYPEPTIDE SUBSTRATES WITHOUT INDUCING TRANSFORMATION
    KAMPS, MP
    BUSS, JE
    SEFTON, BM
    [J]. CELL, 1986, 45 (01) : 105 - 112
  • [17] Likhosherstov A. M., 1993, KHIM FARM ZH, V27, P46
  • [18] TARGETED GENE REPLACEMENT DEMONSTRATES THAT MYRISTOYL-COA/PROTEIN N-MYRISTOYLTRANSFERASE IS ESSENTIAL FOR VIABILITY OF CRYPTOCOCCUS-NEOFORMANS
    LODGE, JK
    JACKSONMACHELSKI, E
    TOFFALETTI, DL
    PERFECT, JR
    GORDON, JI
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (25) : 12008 - 12012
  • [19] Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase.: Part 1
    Masubuchi, M
    Kawasaki, K
    Ebiike, H
    Ikeda, Y
    Tsujii, S
    Sogabe, S
    Fujii, T
    Sakata, K
    Shiratori, Y
    Aoki, Y
    Ohtsuka, T
    Shimma, N
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (14) : 1833 - 1837
  • [20] Characterization of human and rat brain myristoyl-CoA:protein N-myristoyltransferase:: evidence for an alternative splice variant of the enzyme
    McIlhinney, RAJ
    Young, K
    Egerton, M
    Camble, R
    White, A
    Soloviev, M
    [J]. BIOCHEMICAL JOURNAL, 1998, 333 : 491 - 495